Lived experience in patients with recurrent glioblastoma in Japan: A narrative study
Glioblastoma (GBM) is well known to have one of the poorest prognoses among all cancers. Patients with GBM in progression-free survival (PFS) may be relatively stable and can often maintain their quality of life. Thus, PFS is a desirable goal. In Japan, the median PFS is 11 months. It is difficult t...
Saved in:
Main Authors: | Ai Chikada (Author), Asako Takekuma Katsumata (Author), Mariko Asase (Author), Sayaka Takenouchi (Author), Yoshiki Arakawa (Author), Kazuko Nin (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Definition and recommended cultural considerations for advance care planning in Japan: A systematic review
by: Ai Chikada, et al.
Published: (2021) -
Empowering nurses through end-of-life nursing education in Asia: Nurses as advocates for patients' dignity
by: Sayaka Takenouchi
Published: (2018) -
Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
by: Hao Lin, et al.
Published: (2023) -
Factors associated with access to health care among foreign residents living in Aichi Prefecture, Japan: secondary data analysis
by: Michiyo Higuchi, et al.
Published: (2021) -
Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
by: Hong-Hong Zhang, et al.
Published: (2022)